Lipase Elevation in Patients With COVID-19.
Am J Gastroenterol
; 115(8): 1286-1288, 2020 08.
Article
in English
| MEDLINE | ID: covidwho-2324863
ABSTRACT
INTRODUCTION:
Although coronavirus disease (COVID-19) has been associated with gastrointestinal manifestations, its effect on the pancreas remains unclear. We aimed to assess the frequency and characteristics of hyperlipasemia in patients with COVID-19.METHODS:
A retrospective cohort study of hospitalized patients across 6 US centers with COVID-19.RESULTS:
Of 71 patients, 9 (12.1%) developed hyperlipasemia, with 2 (2.8%) greater than 3 times upper limit of normal. No patient developed acute pancreatitis. Hyperlipasemia was not associated with poor outcomes or symptoms.DISCUSSION:
Although a mild elevation in serum lipase was observed in some patients with COVID-19, clinical acute pancreatitis was not seen.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pancreatitis
/
Pneumonia, Viral
/
Coronavirus Infections
/
Lipase
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Limits:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
North America
Language:
English
Journal:
Am J Gastroenterol
Year:
2020
Document Type:
Article
Affiliation country:
Ajg.0000000000000732
Similar
MEDLINE
...
LILACS
LIS